Michael Pishvaian
Physician · Johns Hopkins School of Medicine
Credentials: · · · · · ·
History
- 2020–Present
- 2004–2006
Medical Oncology
- 2001–2004
Internal Medicine
- 1997–2001
Research
The Lancet Oncology · 2020 · First of 16 authors · Corresponding · 455 citations
Journal of Clinical Oncology · 2017 · 412 citations
Prevalence of Homologous Recombination-Related Gene Mutations Across Multiple Cancer Types
JCO Precision Oncology · 2018 · 396 citations
29 papers
20 papers
19 papers
11 papers
11 papers
10 papers
10 papers
- SM
9 papers · 1 as a fellow
Grants
- 1997–2024
Georgetown University Lombardi Comprehensive Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $537.3K · Georgetown University
Clinical trials
- 2015–2017
A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid Tumors
Principal investigator · Terminated · Phase 1
Pfizer
- 2014–2016
Study of Gemcitabine and Abraxane for Pancreas Cancer
Principal investigator · Terminated · Phase 2
Georgetown University
- 2012–2018
Molecularly Tailored Therapy for Pancreas Cancer
Principal investigator · Completed · Phase 2
Georgetown University
- 2011–2020
PD-0332991, 5-FU, and Oxaliplatin for Advanced Solid Tumor Malignancies
Principal investigator · Unknown · Phase 1
Georgetown University